Redeye concludes that Q1 2026 was a clean beat for Litium across every line item. ARR advanced to SEK97.1m, within striking distance of the SEK100m milestone, with year-on-year growth of 17.8%, while EBITDA-CAPEX provided the standout positive surprise, offering early, tangible evidence of operating leverage. Estimate revisions are minor with ARR unchanged, net sales nudged higher, and EBITDA-CAPEX for 2026e improves slightly on the Q1 beat. We maintain our Base Case of SEK19 and a strongly positive view on the investment case.
LÄS MER
